Literature DB >> 14745072

The impact of pregnancy and childbirth on the metabolism of lamotrigine.

P B Pennell1, D J Newport, Z N Stowe, S L Helmers, J Q Montgomery, T R Henry.   

Abstract

This study was performed to clarify alterations in lamotrigine (LTG) clearance during pregnancy and childbirth. Fourteen women on LTG monotherapy had LTG concentration samples obtained before conception and monthly. LTG apparent clearance, weight-adjusted relative clearance, and percentages of baseline clearance significantly differed between preconception baseline and each trimester and between trimesters. LTG clearance progressively increased until 32 weeks' gestational age, reaching a peak of >330% of baseline, and then began to decline.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745072     DOI: 10.1212/01.wnl.0000103286.47129.f8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child.

Authors:  Parvaz Madadi; Shinya Ito
Journal:  Can Fam Physician       Date:  2010-11       Impact factor: 3.275

2.  Do the results of pregnancy registries contradict one another?

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2006 May-Jun       Impact factor: 7.500

3.  EURAP outcomes for seizure control during pregnancy: useful and encouraging data.

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2006 Nov-Dec       Impact factor: 7.500

Review 4.  Epilepsy in pregnancy.

Authors:  Torbjörn Tomson; Vilho Hiilesmaa
Journal:  BMJ       Date:  2007-10-13

5.  Hormones, seizures, and lamotrigine: Oh, my!

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2008 Jan-Feb       Impact factor: 7.500

6.  Some long awaited answers regarding seizures during pregnancy.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsy Curr       Date:  2009 Jan-Feb       Impact factor: 7.500

7.  Regulation of hepatic phase II metabolism in pregnant mice.

Authors:  Xia Wen; Ajay C Donepudi; Paul E Thomas; Angela L Slitt; Roberta S King; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-10-10       Impact factor: 4.030

Review 8.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

Review 9.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

Review 10.  Requirements for generic anti-epileptic medicines: a regulatory perspective.

Authors:  Marc Maliepaard; Yechiel A Hekster; Arnoud Kappelle; Eugène P van Puijenbroek; André J Elferink; Jan Welink; Christine C Gispen-de Wied; Frits J F Lekkerkerker
Journal:  J Neurol       Date:  2009-07-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.